These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 21427606
1. Clinicopathological determinants of vaginal and premalignant-malignant cervico-vaginal polyps of the lower female genital tract. Fauth C, Franko A, Duan Q, Wood S, Duggan MA. J Low Genit Tract Dis; 2011 Jul; 15(3):210-8. PubMed ID: 21427606 [Abstract] [Full Text] [Related]
2. Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies. Wang JH, Zhao J, Lin J. J Minim Invasive Gynecol; 2010 Jul; 17(1):53-8. PubMed ID: 20129333 [Abstract] [Full Text] [Related]
3. The risk of premalignant and malignant pathology in endometrial polyps: should every polyp be resected? Papadia A, Gerbaldo D, Fulcheri E, Ragni N, Menoni S, Zanardi S, Brusacà B. Minerva Ginecol; 2007 Apr; 59(2):117-24. PubMed ID: 17505453 [Abstract] [Full Text] [Related]
4. Clinical significance of a cytologic diagnosis of atypical glandular cells of undetermined significance. Cheng RF, Hernandez E, Anderson LL, Heller PB, Shank R. J Reprod Med; 1999 Nov; 44(11):922-8. PubMed ID: 10589401 [Abstract] [Full Text] [Related]
5. The risk of premalignant and malignant pathology in endometrial polyps. Bakour SH, Khan KS, Gupta JK. Acta Obstet Gynecol Scand; 2000 Apr; 79(4):317-20. PubMed ID: 10746849 [Abstract] [Full Text] [Related]
7. [Premalignant and malignant changes in the uterine cervix in women younger than 30 years]. Postruznik S, Jurić M, Giljanović L, Strmo V. Jugosl Ginekol Perinatol; 1985 Apr; 25(5-6):121-4. PubMed ID: 3837134 [Abstract] [Full Text] [Related]
8. Malignancy in endometrial polyps: a 12-year experience. Baiocchi G, Manci N, Pazzaglia M, Giannone L, Burnelli L, Giannone E, Fratini D, Di Renzo GC. Am J Obstet Gynecol; 2009 Nov; 201(5):462.e1-4. PubMed ID: 19632664 [Abstract] [Full Text] [Related]
9. Cervical polyps in postmenopausal women: is there a difference in risk? Schnatz PF, Ricci S, O'Sullivan DM. Menopause; 2009 Nov; 16(3):524-8. PubMed ID: 19179926 [Abstract] [Full Text] [Related]
10. Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy. Antunes A, Costa-Paiva L, Arthuso M, Costa JV, Pinto-Neto AM. Maturitas; 2007 Aug 20; 57(4):415-21. PubMed ID: 17587515 [Abstract] [Full Text] [Related]
11. Incidence of atypical glandular cells of uncertain significance in cervical cytology following introduction of the Bethesda System. Eddy GL, Ural SH, Strumpf KB, Wojtowycz MA, Piraino PS, Mazur MT. Gynecol Oncol; 1997 Oct 20; 67(1):51-5. PubMed ID: 9345356 [Abstract] [Full Text] [Related]
12. Clinical parameters linked with malignancy in endometrial polyps. Gregoriou O, Konidaris S, Vrachnis N, Bakalianou K, Salakos N, Papadias K, Kondi-Pafiti A, Creatsas G. Climacteric; 2009 Oct 20; 12(5):454-8. PubMed ID: 19591006 [Abstract] [Full Text] [Related]
13. How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study. Ferrazzi E, Zupi E, Leone FP, Savelli L, Omodei U, Moscarini M, Barbieri M, Cammareri G, Capobianco G, Cicinelli E, Coccia ME, Donarini G, Fiore S, Litta P, Sideri M, Solima E, Spazzini D, Testa AC, Vignali M. Am J Obstet Gynecol; 2009 Mar 20; 200(3):235.e1-6. PubMed ID: 19027096 [Abstract] [Full Text] [Related]
15. [Micro-glandular hyperplasia of the uterine cervix. Histo-cytopathological evaluation, differential diagnosis and review of literature]. Daniele E, Nuara R, Morello V, Nagar C, Tralongo V, Tomasino RM. Pathologica; 1993 Feb 20; 85(1100):607-35. PubMed ID: 8170711 [Abstract] [Full Text] [Related]
16. The malignant potential of endometrial polyps. Ben-Arie A, Goldchmit C, Laviv Y, Levy R, Caspi B, Huszar M, Dgani R, Hagay Z. Eur J Obstet Gynecol Reprod Biol; 2004 Aug 10; 115(2):206-10. PubMed ID: 15262357 [Abstract] [Full Text] [Related]
17. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population. Chin AB, Bristow RE, Korst LM, Walts A, Lagasse LD. Am J Obstet Gynecol; 2000 Jun 10; 182(6):1278-82. PubMed ID: 10871439 [Abstract] [Full Text] [Related]
18. Endometrial polyps: symptomatology, menopausal status and malignancy. Golan A, Cohen-Sahar B, Keidar R, Condrea A, Ginath S, Sagiv R. Gynecol Obstet Invest; 2010 Jun 10; 70(2):107-12. PubMed ID: 20332644 [Abstract] [Full Text] [Related]
19. Is the immunohistochemical expression of proliferation (Ki-67) and apoptosis (Bcl-2) markers and cyclooxigenase-2 (COX-2) related to carcinogenesis in postmenopausal endometrial polyps? Antunes A, Andrade LA, Pinto GA, Leão R, Pinto-Neto AM, Costa-Paiva L. Anal Quant Cytopathol Histpathol; 2012 Oct 10; 34(5):264-72. PubMed ID: 23301386 [Abstract] [Full Text] [Related]
20. Misplaced Skene's glands: glandular elements in the lower female genital tract that are variably immunoreactive with prostate markers and that encompass vaginal tubulosquamous polyp and cervical ectopic prostatic tissue. Kelly P, McBride HA, Kennedy K, Connolly LE, McCluggage WG. Int J Gynecol Pathol; 2011 Nov 10; 30(6):605-12. PubMed ID: 21979599 [Abstract] [Full Text] [Related] Page: [Next] [New Search]